Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Factor Xa Inhibitor”

71 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 71 results

Not applicableLooking for participantsNCT05454787
What this trial is testing

Ondexxya for Intravenous Injection 200mg Drug Use Result Investigation (All Case Investigation)

Who this might be right for
Life Threatening BleedingFactor Xa Inhibitor
AstraZeneca 300
Large-scale testing (Phase 3)Study completedNCT02329327
What this trial is testing

A Study in Participants With Acute Major Bleeding to Evaluate the Ability of Andexanet Alfa to Reverse the Anticoagulation Effect of Direct and Indirect Oral Anticoagulants (Extension Study)

Who this might be right for
Bleeding
Alexion Pharmaceuticals, Inc. 479
Testing effectiveness (Phase 2)Study completedNCT01442792
What this trial is testing

Exploring the Efficacy and Safety of Rivaroxaban to Support Elective Percutaneous Coronary Intervention

Who this might be right for
Cardiovascular DiseaseCoronary Artery Disease
Bayer 108
Large-scale testing (Phase 3)Study completedNCT00439777
What this trial is testing

Oral Direct Factor Xa Inhibitor Rivaroxaban in Patients With Acute Symptomatic Pulmonary Embolism - The EINSTEIN PE Study

Who this might be right for
Pulmonary Embolism
Bayer 4,833
Testing effectiveness (Phase 2)Study completedNCT01203098
What this trial is testing

A Phase 2b Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Hip Arthroplasty

Who this might be right for
Venous ThromboembolismThromboembolismThrombosis+3 more
Daiichi Sankyo Co., Ltd. 264
Testing effectiveness (Phase 2)Study completedNCT00938730
What this trial is testing

A Study Evaluating Safety and Tolerability of YM150 Compared to Warfarin in Subjects With Atrial Fibrillation

Who this might be right for
Atrial Fibrillation
Astellas Pharma Inc 1,280
Testing effectiveness (Phase 2)Study completedNCT00839826
What this trial is testing

ODiXahip - a Phase IIa Dose Escalating Proof of Principle Trial

Who this might be right for
ThromboembolismPrevention
Bayer 641
Not applicableStudy completedNCT06147830
What this trial is testing

Describe the Characteristics, Health Care Interventions and Outcomes of Patients With Major Bleedings in the Presence of Factor Xa Inhibitor Treatment

Who this might be right for
Major Bleeding
AstraZeneca 2,202
Testing effectiveness (Phase 2)Study completedNCT00973323
What this trial is testing

BAY59-7939 Japanese in Atrial Fibrillation (2nd)

Who this might be right for
Atrial Fibrillation
Bayer 100
Testing effectiveness (Phase 2)Study completedNCT04640181
What this trial is testing

Factor Xa Inhibitor Versus Standard of Care Heparin in Hospitalized Patients With COVID-19 (XACT)

Who this might be right for
Covid19
St. David's HealthCare 150
Large-scale testing (Phase 3)Study completedNCT00097357
What this trial is testing

BMS-562247 in Subjects Undergoing Elective Total Knee Replacement Surgery

Who this might be right for
Venous ThrombosisPulmonary Embolism
Bristol-Myers Squibb 1,238
Testing effectiveness (Phase 2)Study completedNCT00375609
What this trial is testing

Factor Xa Inhibitor, PRT054021, Against Enoxaparin for the Prevention of Venous Thromboembolic Events (EXPERT)

Who this might be right for
Thromboembolism
Portola Pharmaceuticals 215
Large-scale testing (Phase 3)Study completedNCT05185804
What this trial is testing

Clinical Trial of Dimolegin (DD217) in Prevention of Thrombotic Complications in Patients With COVID-19

Who this might be right for
COVID-19Venous Thromboembolism
PharmaDiall Ltd. 399
Large-scale testing (Phase 3)WithdrawnNCT05926349
What this trial is testing

Andexanet Alfa in Patients Requiring Urgent Surgery or Procedure

Who this might be right for
Urgent Surgery
AstraZeneca
Large-scale testing (Phase 3)Study completedNCT03996772
What this trial is testing

PREvention of STroke in Intracerebral haemorrhaGE Survivors With Atrial Fibrillation

Who this might be right for
Atrial FibrillationIntracerebral Hemorrhage
Imperial College London 319
Large-scale testing (Phase 3)Study completedNCT04142125
What this trial is testing

Combination Antithrombotic Treatment for Prevention of Recurrent Ischemic Stroke in Intracranial Atherosclerotic Disease

Who this might be right for
Ischemic StrokeIntracranial Atherosclerotic Disease
Population Health Research Institute 101
Large-scale testing (Phase 3)Study completedNCT01181102
What this trial is testing

DU-176b, Prevention of Venous Thromboembolism in Patients After Total Knee Arthroplasty

Who this might be right for
Venous Thromboembolism
Daiichi Sankyo Co., Ltd. 716
Testing effectiveness (Phase 2)Study completedNCT00641732
What this trial is testing

Efficacy and Safety of TAK-442 in Subjects Undergoing Total Knee Replacement

Who this might be right for
Venous Thromboembolism
Takeda 1,045
Large-scale testing (Phase 3)Study completedNCT00942435
What this trial is testing

Assess the Effect of YM150 for Prevention of Venous Thromboembolism in Patients Undergoing Major Abdominal Surgery

Who this might be right for
Venous Thromboembolism
Astellas Pharma Inc 156
Large-scale testing (Phase 3)Study completedNCT01028950
What this trial is testing

YM150 for Prevention of Venous Thromboembolism in Patients With Acute Medical Illness

Who this might be right for
Venous Thromboembolism
Astellas Pharma Inc 52
Load More Results